Fairfield Market Research Psychedelic Drugs Market Size, Growth, Analysis 2026
Home / Industry / Pharmaceuticals & Biotechnology / Psychedelic Drugs Market
Psychedelic Drugs Market

Psychedelic Drugs Market

Global Psychedelic Drugs Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2021-2026 - (By Product, By Disease Indication, By Route of Administration, By Origin, By Geography, Leading Companies)

Published Date: Aug 2021 | Format: | No. of Pages: 140

Industry: Pharmaceuticals & Biotechnology | Author Name: Amol

2023 Updates Available

   Back
$4,995.00
Buy now
Request Sample Request Customization More Information
Looking for something
bespoke?
Contact us

Customers also viewed

Retail Pharmacy Market
Projected Retail Pharmacy Market to surge to $1,264.2 billion by 2030, exhibiting a robust CAGR of 10.6%.
Quinine Market
Exploring Quinine Market Growth: Set to Grow from US$2.1 Bn in 2022 to US$3.2 Bn by 2030, with a 6.5% CAGR. Explore the Trends!

FAQ : Psychedelic Drugs Market

Global psychedelic drugs market is anticipated to reach US$6330 Mn by 2026.

Global psychedelic drugs market is anticipated to register a CAGR of 14.5% CAGR between 2021 and 2026.

North America will lead the global psychedelic drugs market as it reaches US$3,184.0 Mn by 2026 from US$1,608.6 Mn in 2021, surging at a CAGR of 14.6% from 2021 to 2026.

Gamma-hydroxybutyric acid (GHB) is anticipated to contribute 37% to the global psychedelic drugs market by the end of 2021.

Intranasal route of administration is slated to exhibit strong CAGR of 17% CAGR with the commercial arrival of Spravato during the forecast period of 2021-2026.
Fairfield Quality assured
Fairfield Confidentiality assured
Fairfield Custom research services